Table 2 presents the associations between TGF-β1 concentrations in patients with early-onset CAD and clinical parameters, including history of diabetes, hypertension, presence of metabolic syndrome, myocardial infarction, impaired ventricular function, and left ventricular hypertrophy. Here, TGFB1 is linked to coronary artery disorder.